Enoch Ng

Assistant Professor

University of Toronto
Country flagCanada

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (7)

Year:

2026

Year:

2026

Objectives: The impact of comorbid posttraumatic stress disorder (PTSD) symptoms on the anti-depressive outcomes of repetitive transcranial magnetic stimulation (rTMS) for civilians with major depressive disorder (MDD) is poorly studied. We aimed to understand whether proximal PTSD symptoms would interact with distal traumas in impacting depression outcomes from rTMS treatment. Methods: A retrospective analysis was performed on 133 patients with MDD receiving open-label high-frequency rTMS to the left dorsolateral prefrontal cortex for 4 weeks. Probable PTSD was defined as scoring ≥ 4 on the Primary Care PTSD Screen for DSM-5. Distal traumas were quantified using the Adverse Childhood Experiences (ACE-10) questionnaire. Primary outcomes were improvement in Hamilton Rating Scale for Depression 17 item scale (HAMD-17) scores from baseline to 4 weeks as well as remission (HAMD-17 ≤ 7) and response (greater than 50% improvement from baseline). Results: 29/133 had probable PTSD. Patients with probable PTSD had more ACEs, as well as higher depression, anxiety and medical comorbidity scores. Neither probable PTSD status nor its interaction with ACEs significantly impacted depression outcomes. However, having more ACEs was associated with greater odds of remission and response. Conclusions: Our findings suggest neither co-morbid PTSD symptoms nor distal childhood adversities should preclude patients with MDD from receiving rTMS for depression. Plain Language Summary Title Repetitive transcranial magnetic stimulation for civilian patients with depression and posttraumatic stress symptoms

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Collaborators (4)

Sean Nestor

Assistant Professor

University of Toronto

CANADA
View details

Peter Giacobbe

Clinical Head, Harquail Centre for Neuromodulation

Sunnybrook Health Sciences Centre

CANADA
View details

Clement Hamani

Sunnybrook Research Institute

CANADA
View details

Alexandre Boutet

University of Toronto

CANADA
View details